Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FMJ8J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,436
Award facts
- Contract value 100% obligated
- $49,435.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $49,435.73 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick autoinjector pens, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract was issued on January 2, 2026, with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order fulfills a specific pharmaceutical supply requirement within the federal medical procurement process.
This award represents a routine pharmaceutical procurement under AmerisourceBergen Drug Corp's broader relationship with the Defense Logistics Agency, specifically its Troop Support Medical division. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Repatha (evolocumab) is a PCSK9 inhibitor used for cholesterol management and cardiovascular disease prevention, consistent with AmerisourceBergen's portfolio of specialty medications supplied to Defense Health Agency systems and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26FMJ8J?
SPE2DR26FMJ8J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26FMJ8J worth?
The government has obligated $49,436 on SPE2DR26FMJ8J.
Is contract SPE2DR26FMJ8J an order under another contract?
Yes. SPE2DR26FMJ8J is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMJ8J competed?
The extent of competition for SPE2DR26FMJ8J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award